1. Home
  2. NOTV vs SACH Comparison

NOTV vs SACH Comparison

Compare NOTV & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.85

Market Cap

29.9M

Sector

Health Care

ML Signal

HOLD

Logo Sachem Capital Corp.

SACH

Sachem Capital Corp.

HOLD

Current Price

$1.13

Market Cap

48.6M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOTV
SACH
Founded
1974
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
29.9M
48.6M
IPO Year
1997
2017

Fundamental Metrics

Financial Performance
Metric
NOTV
SACH
Price
$0.85
$1.13
Analyst Decision
Strong Buy
Hold
Analyst Count
1
3
Target Price
$3.00
$2.00
AVG Volume (30 Days)
1.6M
155.8K
Earning Date
12-03-2025
11-05-2025
Dividend Yield
N/A
19.13%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$513,024,000.00
$3,906,000.00
Revenue This Year
$6.26
N/A
Revenue Next Year
$45.49
$1.73
P/E Ratio
N/A
N/A
Revenue Growth
4.54
N/A
52 Week Low
$0.66
$0.80
52 Week High
$6.48
$1.48

Technical Indicators

Market Signals
Indicator
NOTV
SACH
Relative Strength Index (RSI) 39.03 59.48
Support Level $0.84 $1.00
Resistance Level $0.95 $1.08
Average True Range (ATR) 0.11 0.05
MACD 0.02 0.01
Stochastic Oscillator 51.27 77.83

Price Performance

Historical Comparison
NOTV
SACH

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About SACH Sachem Capital Corp.

Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.

Share on Social Networks: